On the 30th anniversary of the listing, employees have something to say.
Release time:
2023-06-07
Fan Tufa (General Department of Pharmaceutical Company):
I am a "Second Generation of Peak". I entered Peak in April 1981. At that time, I was Jinhua Cement Factory, the predecessor of the group located at the foot of Peak Mountain. The 42-year experience in the peak was very simple. For the first 30 years, I worked in the company's clinic, starting with the clinic of Jinhua Cement Factory, then changed to the clinic of the group company. After August 2011, I transferred to Jinhua Pharmaceutical Company to do administrative and logistics management. After that, I added party affairs, trade unions and other aspects of work
. After working in the peak for so many years, my greatest gain was the growth of life. Here, from the students who have just left school to the real starting point of life, to the society, to start a family and start a career, to the present career has some achievements, all of which are obtained in the social university of the peak. In the past 40 years, I have personally felt the entrepreneurial spirit, dedication and innovative spirit of the peak people, and felt the courage and courage of the peak people to seize opportunities and dare to take the edge. From a poor and white small cement factory to a cross-industry and cross-regional comprehensive group company, all embody the wisdom and hardships of several generations of peak people, and all embody the unremitting efforts of several generations of peak people. this is the most precious spiritual wealth that peak has accumulated for more than 60 years, and it is also my greatest feeling and harvest in the past 40 years.
I have been in the peak for 42 years, and I am about to retire. I will try my best to do my present work well, do as many things as possible, and do my part for the development of the group. Do a good job in spreading help, set a good example of righteousness, pass on the fine tradition of peak to the young generation of peak people, and pass on my little business knowledge and work experience to the young generation of peak people, make them the baton of the centennial spike as early as possible.
At the same time, I also thank Jianfeng for giving me a platform for learning and growth in life, allowing me to become a person who is responsible and grateful to society, business, and family. I also hope that all peak people can sincerely unite and work together in the increasingly fierce competition in the industry, so that our company can overcome temporary difficulties and continue to maintain healthy and stable development. I wish the peak to create another great cause, re-cast glory, a hundred years of grand plans, and fulfill my wish! Looking forward to being present at the celebration of the centenary of the peak.
Wang Xi Ming (Finance Department of Pharmaceutical Company):
In December 1994 , I was recruited as a contract employee to work in Bailongqiao Branch of Jinhua Pharmaceutical Company. After entering the company for a few years, in June 1999, after public bidding, Jianfeng Group bought out Jinhua Pharmaceutical Company at one time. At this point, I also officially became a member of the spike.
In the big family of peak, I started with the most basic work of finance. I worked as a cashier, a commodity bookkeeper and a sales accountant successively. I slowly learned from myself and taught by my predecessors. At present, I am a relatively mature financial accountant, mainly responsible for the comprehensive profit statement of pharmaceutical companies.
What impressed me most was the working attitude of the peak financiers, the seriousness, care and rigor of the financial staff and the mutual trust and collaboration of the financial team. Over the past 20 years, I have deeply felt the unity and mutual assistance of the peak people. In the face of continuous personnel optimization, everyone has become a versatile person. They can properly arrange the daily work content according to their priorities, and voluntarily help each other., Complete each task on time with quality and quantity, and work overtime without complaint. There is also the fact that peak people can not flinch when things happen, try every means to actively communicate and cooperate with relevant departments, and can properly coordinate and solve problems, which shows the fighting spirit and skillful ability of peak people when things happen. Because of such a strong and professional team, peak has its own place in the long volume of history and its own brilliant moment.
On the occasion of the 30th anniversary of the listing of the peak, I also sincerely wish the peak can carry on the past, climb the peak bravely and create another glory! I wish the profit statement of the peak group has increased year by year, and the income of the peak people has increased year by year! 22
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page